Synthesis and biological evaluation of 6',7'-dihydroxybergamottin (6,7-DHB), a naturally occurring inhibitor of cytochrome P450 3A4

被引:18
|
作者
Bellevue, FH
Woster, PM
Edwards, DJ
He, K
Hollenberg, PF
机构
[1] WAYNE STATE UNIV, DEPT PHARMACEUT SCI, DETROIT, MI 48202 USA
[2] WAYNE STATE UNIV, DEPT PHARM PRACTICE, DETROIT, MI 48202 USA
[3] UNIV MICHIGAN, DEPT PHARMACOL, ANN ARBOR, MI 49109 USA
关键词
D O I
10.1016/S0960-894X(97)10043-9
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The recently isolated inhibitor of cytochrome P450 CYP3A4, 6',7'-dihydroxybergamottin (6,7-DHB), was synthesized by an efficient route that is readily adaptable to the production of analogues. The compound was evaluated as an inhibitor of 3A4 in a purified enzyme preparation, as well as against human liver microsomes and human 3A4 expressed in Escherichia coli membrane. In each case, 6,7-DHB proved to be a potent NADPH-and time dependent inactivator of 3A4. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:2593 / 2598
页数:6
相关论文
共 50 条
  • [41] Evaluation of the inhibition of chlorophenols towards human cytochrome P450 3A4 and differences among various species
    Liu, Nai-Rong
    Yang, Kai
    Li, Wen-Ting
    Pang, Zhi-Hua
    Zhang, Qing
    Wang, Jia-Jia
    Dang, Wen-Xi
    Jia, Ruo-Yong
    Fu, Zhi-Wei
    Li, Yi-Xuan
    Yao, Zhu-Hua
    Fang, Zhong-Ze
    SCIENCE OF THE TOTAL ENVIRONMENT, 2020, 724
  • [42] Bergamottin and 6′,7′-dihydroxybergamottin block TNF-a stimulated MAdCAM-1 expression, by inhibition of cytochrome P450 momooxygenase derived oxidants
    Sasaki, M
    Jordan, P
    Alexander, J
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S319 - S319
  • [43] Inhibition models for cytochrome P450 1A2, 2C9, 2D6, and 3A4
    Zhuang, Dechuan
    Zhang, Jinhua
    Fraczkiewicz, Robert
    Bolger, Michael B.
    Waldman, Marvin
    Woltosz, Walter S.
    Enslein, Kurt
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [44] Predicting Drug Metabolism by Cytochrome P450 2C9: Comparison with the 2D6 and 3A4 Isoforms
    Rydberg, Patrik
    Olsen, Lars
    CHEMMEDCHEM, 2012, 7 (07) : 1202 - 1209
  • [45] Pregnane X receptor is required for interleukin-6-mediated down-regulation of cytochrome P450 3A4 in human hepatocytes
    Yang, Jian
    Hao, Chunshu
    Yang, Dongfang
    Shi, Deshi
    Song, Xiulong
    Luan, Xiaofei
    Hu, Gang
    Yan, Bingfang
    TOXICOLOGY LETTERS, 2010, 197 (03) : 219 - 226
  • [46] Interaction study of engeletin toward cytochrome P450 3A4 and 2D6 by multi-spectroscopy and molecular docking
    Fan, Yangyang
    Tao, Yanzhou
    Liu, Guiming
    Wang, Meizi
    Wang, Suqing
    Li, Li
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2022, 264
  • [47] Modelling cytochrome P450 inhibition using large datasets of in vitro assays for CYP 2D6 and CYP 3A4
    Mao, B
    Gozalbes, R
    Barbosa, F
    Migeon, J
    Rogalski, S
    Kamm, K
    Wong, E
    Costales, C
    Shi, W
    Froloff, N
    Horvath, D
    Wu, C
    DRUG METABOLISM REVIEWS, 2004, 36 : 343 - 343
  • [48] Effects of Cytochrome P450 3A4 Induction and Inhibition on the Pharmacokinetics of BI 425809, a Novel Glycine Transporter 1 Inhibitor
    Desch, Michael
    Wunderlich, Glen
    Goettel, Markus
    Goetz, Sophia
    Liesenfeld, Karl-Heinz
    Chan, Tom S.
    Rosenbrock, Holger
    Sennewald, Regina
    Link, Jasmin
    Keller, Sascha
    Wind, Sven
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2022, 47 (01) : 91 - 103
  • [49] High-throughput approaches to the quantitative analysis of ketoconazole, a potent inhibitor of cytochrome P450 3A4, in human plasma
    Ramos, L.
    Brignol, N.
    Bakhtiar, R.
    Ray, T.
    Mc Mahon, L.M.
    Tse, F.L.S.
    2000, John Wiley and Sons Ltd (14)
  • [50] High-throughput approaches to the quantitative analysis of ketoconazole, a potent inhibitor of cytochrome P450 3A4, in human plasma
    Ramos, L
    Brignol, N
    Bakhtiar, R
    Ray, T
    McMahon, LM
    Tse, FLS
    RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2000, 14 (23) : 2282 - 2293